ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2020

Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes.

Fu-Ping Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.